On June 13, 2025, Dave & Buster’s Entertainment, Inc. (the “Company”) announced the retirement of John Mulleady, Chief Development Officer and a named executive officer.
On June 13, 2025, NextDecade Corporation (the “Company”) received a letter from Mr. Timothy Wyatt indicating that he was resigning from the Company's Board of Directors (the “Board”), effective immediately.
On June 10, 2025, SRx Health Solutions, Inc. (the “ Company ”) accepted the voluntary resignation of Davender Sohi as the President of the Company, effective immediately.
Kent Cunningham, 54, has been appointed as President of the Company; Adesh Vora, 49, has been appointed as Chief Executive Officer of the Company; and Lionel Conacher, 62, has been appointed as Chairman of the Board, in each case effective June 11, 2025.
Kent Cunningham, 54, has been appointed as President of the Company; Adesh Vora, 49, has been appointed as Chief Executive Officer of the Company; and Lionel Conacher, 62, has been appointed as Chairman of the Board, in each case effective June 11, 2025.
Kent Cunningham, 54, has been appointed as President of the Company; Adesh Vora, 49, has been appointed as Chief Executive Officer of the Company; and Lionel Conacher, 62, has been appointed as Chairman of the Board, in each case effective June 11, 2025.
On June 10, 2025, Newton Golf Company, Inc. (the “Company”) announced that the Board of Directors (the “Board”) of the Company has appointed Jeff Clayborne to serve as the Company’s Chief Financial Officer, principal financial officer and principal accounting officer, effective June 10, 2025
On June 13, 2025, Imunon, Inc. (the “Company”) terminated the consulting agreement (as amended, the “Agreement”), dated April 15, 2024, by and between the Company and Monomoy Advisors, LLC, a financial advisory services firm (“Monomoy”), as well as David Gaiero’s service pursuant to the Agreement as the Company’s interim Chief Financial Officer (a position he has held since June of 2024), in each case effective June 13, 2025.
As a result of the termination of the Agreement and Mr. Gaiero’s related service, effective June 13, 2025, the Company appointed Kimberly Graper to serve as the Company’s interim Chief Financial Officer.
On June 13, 2025, the Board of Directors of the Company (with Mr. Lagan abstaining) appointed Seamus Lagan to serve as the Company’s Interim Chief Financial Officer.
On June 9, 2025, Zscaler, Inc. (the “Company”) entered into a Transition Agreement and Release (the “Transition Agreement”) with Remo Canessa, in connection with his previously disclosed retirement.
Appointed
Noam Kenig
Director
Bannix Acquisition Corp.
Filed
June 13, 2025, 7:59 PM ET
VisionWave Holdings, Inc. is expected to have the following five directors post-closing: ● Douglas Davis ● Noam Kenig ● Eric T. Shuss ● Chuck Hansen ● Haggai Ravid
Appointed
Haggai Ravid
Director
Bannix Acquisition Corp.
Filed
June 13, 2025, 7:59 PM ET
VisionWave Holdings, Inc. is expected to have the following five directors post-closing: ● Douglas Davis ● Noam Kenig ● Eric T. Shuss ● Chuck Hansen ● Haggai Ravid
Appointed
Douglas Davis
Director
Bannix Acquisition Corp.
Filed
June 13, 2025, 7:59 PM ET
VisionWave Holdings, Inc. is expected to have the following five directors post-closing: ● Douglas Davis ● Noam Kenig ● Eric T. Shuss ● Chuck Hansen ● Haggai Ravid
Appointed
Eric T. Shuss
Director
Bannix Acquisition Corp.
Filed
June 13, 2025, 7:59 PM ET
VisionWave Holdings, Inc. is expected to have the following five directors post-closing: ● Douglas Davis ● Noam Kenig ● Eric T. Shuss ● Chuck Hansen ● Haggai Ravid
Appointed
Chuck Hansen
Director
Bannix Acquisition Corp.
Filed
June 13, 2025, 7:59 PM ET
VisionWave Holdings, Inc. is expected to have the following five directors post-closing: ● Douglas Davis ● Noam Kenig ● Eric T. Shuss ● Chuck Hansen ● Haggai Ravid
Role change
James Pesoli
Chief Executive Officer
Healthtech Solutions, Inc./UT
Effective
2025-06-06
Filed
June 13, 2025, 7:59 PM ET
James Pesoli, the president and a director of the Company, was appointed as the chief executive officer of the Company.
Departed
Jelena Olmstead
Chief Executive Officer and Director
Healthtech Solutions, Inc./UT
Effective
2025-06-06
Successor
James Pesoli
Filed
June 13, 2025, 7:59 PM ET
Jelena Olmstead, who served as chief executive officer and a director of the Company, resigned as a director, officer and employee of the Company and HTWC.
Ms. Robertson’s role of General Counsel and Secretary is being filled on an interim basis by Aaron Gunderson, Associate General Counsel while Pentair makes its selection for its next General Counsel and Secretary.
On June 12, 2025, Interface, Inc. (the “Company”) and Nigel Stansfield, the Company’s Chief Innovation & Sustainability Officer, announced that the Company will eliminate the position of Chief Innovation & Sustainability Officer held by Mr. Stansfield later this year.
On June 10, 2025, the Board of Directors of Sterling Infrastructure, Inc. (the Company) appointed Nicholas Grindstaff, age 62, as its Chief Financial Officer (CFO) and designated him as its principal accounting officer, effective July 10, 2025
As part of the transition, Mr. Ballschmiede will continue as Executive Vice President until his retirement expected in 2025 in order to assist Mr. Grindstaff.
Micah Young, Chief Financial Officer, has recently assumed leadership of the corporate development function in addition to his responsibilities overseeing finance, IT and investor relations.
elected Carol A. Clements as a director, effective immediately.
Departed
Charles Riceman
Co-President
Varagon Capital Corp
Effective
2025-06-06
Filed
June 12, 2025, 7:59 PM ET
On June 6, 2025, Charles Riceman and Varagon Capital Corporation (the “Company”) agreed that Mr. Riceman will retire from his position as Co-President of the Company, effective immediately.
Role change
Kevin Marchetti
President
Varagon Capital Corp
Effective
2025-06-06
Filed
June 12, 2025, 7:59 PM ET
Kevin Marchetti, who along with Mr. Riceman was Co-President of the Company, was appointed as the President of the Company by the Company’s board of directors, effective immediately.
On June 12, 2025, Onto Innovation, Inc. (the “Company” or “Onto Innovation”) and Mr. Mark Slicer, the Company’s Chief Financial Officer (“CFO”), agreed to mutually terminate Mr. Slicer’s employment with the Company, effective immediately.
On June 10, 2025, Thomas F. Frist, III submitted his resignation to the Board of Directors of VeriSign, Inc. (the "Company"), citing other personal and professional time commitments.
Mr. Shepard succeeds Nicholas DeIuliis in the role of Company President (Mr. DeIuliis continues to serve as the Company’s Chief Executive Officer and as a member of the Board).
On June 11, 2025, the Board of Directors (the “Board”) of CNX Resources Corporation (“the Company”) appointed Alan Shepard, the Company’s current Chief Financial Officer, to serve as the Company’s President in addition to his role as Chief Financial Officer, effective immediately.
On June 10, 2025, the Board of Directors of Cyber Enviro-Tech, Inc. (the “Company”) appointed Mr. Dan Leboffe and Ms. Brook Brost to serve as members of the Company’s Board of Directors, effective immediately.
On June 10, 2025, the Board of Directors of Cyber Enviro-Tech, Inc. (the “Company”) appointed Mr. Dan Leboffe and Ms. Brook Brost to serve as members of the Company’s Board of Directors, effective immediately.
Ting (Tim) Xiao did not stand for re-election at the expiration of his term ending at the Annual Meeting, and, accordingly, as of the conclusion of the Annual Meeting Mr. Xiao’s term ended with his resignation from the Board of Directors of the Company
Effective June 10, 2025, Messrs. William Mercer, Robert C. Merton, Mitchell Pressman, and John (Jack) L. Sennott, Jr. (collectively, the “Elected Directors”) were elected to the board of directors of the Company.
Effective June 10, 2025, Messrs. William Mercer, Robert C. Merton, Mitchell Pressman, and John (Jack) L. Sennott, Jr. (collectively, the “Elected Directors”) were elected to the board of directors of the Company.
Effective June 10, 2025, Messrs. William Mercer, Robert C. Merton, Mitchell Pressman, and John (Jack) L. Sennott, Jr. (collectively, the “Elected Directors”) were elected to the board of directors of the Company.
Effective June 10, 2025, Messrs. William Mercer, Robert C. Merton, Mitchell Pressman, and John (Jack) L. Sennott, Jr. (collectively, the “Elected Directors”) were elected to the board of directors of the Company.
Appointed
Holly Kordasiewicz
executive vice president and chief development officer
On June 12, 2025, the Company issued a press release announcing that Holly Kordasiewicz, Ph.D., currently senior vice president, neurology, will succeed Dr. Richard Geary Ph.D. in the role of executive vice president and chief development officer beginning in January 2026.
Departed
Richard Geary
executive vice president and chief development officer
On June 12, 2025, Ionis Pharmaceuticals, Inc. (the “ Company ”) issued a press release announcing that Richard Geary Ph.D., executive vice president and chief development officer, will retire effective January 2026.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.